Latest Breaking News On - Ipi nivo - Page 1 : vimarsana.com

Small Cell Lung Cancer: What is the Role of IO Therapy in the Frontline Setting?

A brief review of the role that immunotherapy agents play in the frontline management of patients with small cell lung cancer.

Relapsed/Refractory Clear Cell RCC: Novel Treatment Strategies

Switching their focus to relapsed/refractory advanced clear cell renal cell carcinoma, key opinion leaders review treatment options in this setting.

Role of Combination Immunotherapy in Metastatic Renal Cell Carcinoma

Key opinion leaders in the field of renal cell carcinoma management discuss the advent of combination immunotherapy in patients with metastatic disease.

Scenario 1: A 47-Year-Old Man With Intermediate Risk Metastatic RCC

Expert perspectives on a patient scenario of intermediate risk metastatic renal cell carcinoma and corresponding management with combination immunotherapy.

Selecting Therapy for Advanced NSCLC Based on PDL1 and NGS Testing

Shared insight on the value that molecular testing and PDL1 testing, respectively, have on determining optimal therapy for patients with advanced non–small cell lung cancer.

burpeejump_文学城博客

MacroGenics (MGNX) Q4 2021 Earnings Call Transcript

MGNX earnings call for the period ending December 31, 2021.